23/10/2026
The US Food and Drug Administration (FDA) has approved Olumiant (baricitinib) for patients aged 12 years and older with severe alopecia areata, expanding the treatment’s existing approval for adults with the condition.
Read More: https://www.e-health.market/industry_news/fda-approves-olumiant-for-adolescents-with-severe-alopecia-areata
Eli Lilly and Company U.S. Food and Drug Administration